nodes	percent_of_prediction	percent_of_DWPC	metapath
Gefitinib—HIPK4—female reproductive system—rectum cancer	0.0194	0.0298	CbGeAlD
Gefitinib—CSNK1E—seminal vesicle—rectum cancer	0.0168	0.0258	CbGeAlD
Gefitinib—IRAK4—seminal vesicle—rectum cancer	0.0165	0.0254	CbGeAlD
Gefitinib—CHEK2—vagina—rectum cancer	0.0154	0.0238	CbGeAlD
Gefitinib—MKNK2—seminal vesicle—rectum cancer	0.0154	0.0237	CbGeAlD
Gefitinib—EPHA6—female reproductive system—rectum cancer	0.0153	0.0236	CbGeAlD
Gefitinib—ERBB3—epithelium—rectum cancer	0.0141	0.0216	CbGeAlD
Gefitinib—MAP3K19—female reproductive system—rectum cancer	0.0139	0.0214	CbGeAlD
Gefitinib—MKNK2—epithelium—rectum cancer	0.0134	0.0206	CbGeAlD
Gefitinib—CSNK1E—urethra—rectum cancer	0.0133	0.0204	CbGeAlD
Gefitinib—EGFR—mammalian vulva—rectum cancer	0.0131	0.0202	CbGeAlD
Gefitinib—IRAK4—urethra—rectum cancer	0.0131	0.0201	CbGeAlD
Gefitinib—ERBB3—renal system—rectum cancer	0.013	0.0201	CbGeAlD
Gefitinib—MKNK2—smooth muscle tissue—rectum cancer	0.0129	0.0198	CbGeAlD
Gefitinib—IRAK1—smooth muscle tissue—rectum cancer	0.0129	0.0198	CbGeAlD
Gefitinib—CSNK1E—mammalian vulva—rectum cancer	0.0126	0.0195	CbGeAlD
Gefitinib—IRAK4—mammalian vulva—rectum cancer	0.0124	0.0191	CbGeAlD
Gefitinib—MKNK2—renal system—rectum cancer	0.0124	0.0191	CbGeAlD
Gefitinib—MKNK2—urethra—rectum cancer	0.0122	0.0187	CbGeAlD
Gefitinib—MKNK1—urethra—rectum cancer	0.012	0.0185	CbGeAlD
Gefitinib—MKNK2—mammalian vulva—rectum cancer	0.0116	0.0178	CbGeAlD
Gefitinib—IRAK1—mammalian vulva—rectum cancer	0.0116	0.0178	CbGeAlD
Gefitinib—SBK1—lymph node—rectum cancer	0.0115	0.0176	CbGeAlD
Gefitinib—MKNK1—mammalian vulva—rectum cancer	0.0114	0.0176	CbGeAlD
Gefitinib—MAP2K5—seminal vesicle—rectum cancer	0.0112	0.0172	CbGeAlD
Gefitinib—CSNK1E—female reproductive system—rectum cancer	0.0108	0.0167	CbGeAlD
Gefitinib—ERBB3—female reproductive system—rectum cancer	0.0104	0.0161	CbGeAlD
Gefitinib—STK10—renal system—rectum cancer	0.0101	0.0155	CbGeAlD
Gefitinib—CHEK2—lymph node—rectum cancer	0.00998	0.0154	CbGeAlD
Gefitinib—MKNK2—female reproductive system—rectum cancer	0.00993	0.0153	CbGeAlD
Gefitinib—IRAK1—female reproductive system—rectum cancer	0.00993	0.0153	CbGeAlD
Gefitinib—MKNK1—female reproductive system—rectum cancer	0.0098	0.0151	CbGeAlD
Gefitinib—CSNK1E—vagina—rectum cancer	0.00979	0.0151	CbGeAlD
Gefitinib—IRAK4—vagina—rectum cancer	0.00963	0.0148	CbGeAlD
Gefitinib—STK10—mammalian vulva—rectum cancer	0.00943	0.0145	CbGeAlD
Gefitinib—MKNK2—vagina—rectum cancer	0.00898	0.0138	CbGeAlD
Gefitinib—MKNK1—vagina—rectum cancer	0.00886	0.0136	CbGeAlD
Gefitinib—MAP2K5—urethra—rectum cancer	0.00884	0.0136	CbGeAlD
Gefitinib—MAP2K5—mammalian vulva—rectum cancer	0.00842	0.013	CbGeAlD
Gefitinib—STK10—female reproductive system—rectum cancer	0.00807	0.0124	CbGeAlD
Gefitinib—STK10—vagina—rectum cancer	0.0073	0.0112	CbGeAlD
Gefitinib—MAP2K5—female reproductive system—rectum cancer	0.00721	0.0111	CbGeAlD
Gefitinib—EGFR—lymph node—rectum cancer	0.00658	0.0101	CbGeAlD
Gefitinib—MAP2K5—vagina—rectum cancer	0.00652	0.01	CbGeAlD
Gefitinib—CSNK1E—lymph node—rectum cancer	0.00633	0.00974	CbGeAlD
Gefitinib—IRAK4—lymph node—rectum cancer	0.00623	0.00959	CbGeAlD
Gefitinib—ERBB3—lymph node—rectum cancer	0.00611	0.0094	CbGeAlD
Gefitinib—ORM1—female reproductive system—rectum cancer	0.00585	0.00901	CbGeAlD
Gefitinib—MKNK2—lymph node—rectum cancer	0.00581	0.00894	CbGeAlD
Gefitinib—IRAK1—lymph node—rectum cancer	0.00581	0.00894	CbGeAlD
Gefitinib—MKNK1—lymph node—rectum cancer	0.00573	0.00883	CbGeAlD
Gefitinib—ABCG2—seminal vesicle—rectum cancer	0.00543	0.00837	CbGeAlD
Gefitinib—STK10—lymph node—rectum cancer	0.00472	0.00727	CbGeAlD
Gefitinib—CYP1A1—epithelium—rectum cancer	0.00448	0.0069	CbGeAlD
Gefitinib—ABCG2—urethra—rectum cancer	0.0043	0.00662	CbGeAlD
Gefitinib—MAP2K5—lymph node—rectum cancer	0.00422	0.00649	CbGeAlD
Gefitinib—CYP1A1—renal system—rectum cancer	0.00416	0.0064	CbGeAlD
Gefitinib—ABCG2—mammalian vulva—rectum cancer	0.00409	0.0063	CbGeAlD
Gefitinib—CYP1A1—urethra—rectum cancer	0.00408	0.00629	CbGeAlD
Gefitinib—CYP3A5—renal system—rectum cancer	0.00406	0.00626	CbGeAlD
Gefitinib—CYP1A1—mammalian vulva—rectum cancer	0.00389	0.00599	CbGeAlD
Gefitinib—CYP2C19—vagina—rectum cancer	0.00374	0.00575	CbGeAlD
Gefitinib—ORM1—lymph node—rectum cancer	0.00342	0.00527	CbGeAlD
Gefitinib—CYP1A1—female reproductive system—rectum cancer	0.00333	0.00513	CbGeAlD
Gefitinib—CYP2C9—female reproductive system—rectum cancer	0.0032	0.00493	CbGeAlD
Gefitinib—ABCG2—vagina—rectum cancer	0.00317	0.00488	CbGeAlD
Gefitinib—CYP3A4—renal system—rectum cancer	0.00305	0.0047	CbGeAlD
Gefitinib—CYP1A1—vagina—rectum cancer	0.00301	0.00464	CbGeAlD
Gefitinib—ALB—lymph node—rectum cancer	0.003	0.00462	CbGeAlD
Gefitinib—CYP2D6—renal system—rectum cancer	0.003	0.00462	CbGeAlD
Gefitinib—CYP3A5—vagina—rectum cancer	0.00294	0.00453	CbGeAlD
Gefitinib—ABCB1—seminal vesicle—rectum cancer	0.00268	0.00413	CbGeAlD
Gefitinib—CYP3A4—female reproductive system—rectum cancer	0.00244	0.00376	CbGeAlD
Gefitinib—CYP2D6—female reproductive system—rectum cancer	0.0024	0.0037	CbGeAlD
Gefitinib—ABCB1—epithelium—rectum cancer	0.00233	0.00358	CbGeAlD
Gefitinib—ABCB1—renal system—rectum cancer	0.00216	0.00332	CbGeAlD
Gefitinib—ABCB1—urethra—rectum cancer	0.00212	0.00327	CbGeAlD
Gefitinib—ABCG2—lymph node—rectum cancer	0.00205	0.00316	CbGeAlD
Gefitinib—ABCB1—mammalian vulva—rectum cancer	0.00202	0.00311	CbGeAlD
Gefitinib—CYP1A1—lymph node—rectum cancer	0.00195	0.003	CbGeAlD
Gefitinib—ABCB1—female reproductive system—rectum cancer	0.00173	0.00266	CbGeAlD
Gefitinib—ABCB1—vagina—rectum cancer	0.00156	0.00241	CbGeAlD
Gefitinib—ABCB1—lymph node—rectum cancer	0.00101	0.00156	CbGeAlD
Gefitinib—ALB—Transmembrane transport of small molecules—SLC14A2—rectum cancer	0.000801	0.00229	CbGpPWpGaD
Gefitinib—ERBB3—Fc epsilon receptor (FCERI) signaling—NRAS—rectum cancer	0.000794	0.00226	CbGpPWpGaD
Gefitinib—ERBB3—DAP12 interactions—NRAS—rectum cancer	0.000794	0.00226	CbGpPWpGaD
Gefitinib—ERBB3—Signaling by FGFR in disease—NRAS—rectum cancer	0.000794	0.00226	CbGpPWpGaD
Gefitinib—EGFR—SHP2 signaling—HRAS—rectum cancer	0.000789	0.00225	CbGpPWpGaD
Gefitinib—ERBB3—Signaling by EGFR—NRAS—rectum cancer	0.000787	0.00224	CbGpPWpGaD
Gefitinib—ERBB3—Downstream signaling of activated FGFR—KRAS—rectum cancer	0.000784	0.00224	CbGpPWpGaD
Gefitinib—ERBB3—Signaling by EGFR in Cancer—NRAS—rectum cancer	0.00078	0.00222	CbGpPWpGaD
Gefitinib—ERBB3—Signaling by PDGF—NRAS—rectum cancer	0.000776	0.00221	CbGpPWpGaD
Gefitinib—ERBB3—Signaling by ERBB4—KRAS—rectum cancer	0.000772	0.0022	CbGpPWpGaD
Gefitinib—EPHA6—Axon guidance—NRAS—rectum cancer	0.000761	0.00217	CbGpPWpGaD
Gefitinib—MAP2K5—EGF/EGFR Signaling Pathway—KRAS—rectum cancer	0.000761	0.00217	CbGpPWpGaD
Gefitinib—MAP2K5—MAPK Signaling Pathway—KRAS—rectum cancer	0.000739	0.00211	CbGpPWpGaD
Gefitinib—ERBB3—Downstream signal transduction—KRAS—rectum cancer	0.000737	0.0021	CbGpPWpGaD
Gefitinib—EGFR—Rac1/Pak1/p38/MMP-2 pathway—TP53—rectum cancer	0.000735	0.0021	CbGpPWpGaD
Gefitinib—ERBB3—B Cell Activation—NRAS—rectum cancer	0.000734	0.0021	CbGpPWpGaD
Gefitinib—ERBB3—Signaling by FGFR—KRAS—rectum cancer	0.000733	0.00209	CbGpPWpGaD
Gefitinib—ERBB3—Signaling by ERBB2—KRAS—rectum cancer	0.00073	0.00208	CbGpPWpGaD
Gefitinib—EGFR—LPA receptor mediated events—HRAS—rectum cancer	0.000729	0.00208	CbGpPWpGaD
Gefitinib—MAP2K5—NGF signalling via TRKA from the plasma membrane—NRAS—rectum cancer	0.000729	0.00208	CbGpPWpGaD
Gefitinib—ERBB3—DAP12 signaling—KRAS—rectum cancer	0.000726	0.00207	CbGpPWpGaD
Gefitinib—CSNK1E—Circadian rythm related genes—TP53—rectum cancer	0.00072	0.00205	CbGpPWpGaD
Gefitinib—IRAK1—Signaling by Interleukins—HRAS—rectum cancer	0.000718	0.00205	CbGpPWpGaD
Gefitinib—ERBB3—Downstream signaling events of B Cell Receptor (BCR)—KRAS—rectum cancer	0.000716	0.00204	CbGpPWpGaD
Gefitinib—MAP2K5—BDNF signaling pathway—HRAS—rectum cancer	0.00071	0.00203	CbGpPWpGaD
Gefitinib—CYP1A1—Aryl Hydrocarbon Receptor—KRAS—rectum cancer	0.000706	0.00201	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways in Glioblastoma—KRAS—rectum cancer	0.000704	0.00201	CbGpPWpGaD
Gefitinib—EGFR—Rac1/Pak1/p38/MMP-2 pathway—HRAS—rectum cancer	0.000703	0.00201	CbGpPWpGaD
Gefitinib—ERBB3—NGF signalling via TRKA from the plasma membrane—NRAS—rectum cancer	0.000703	0.00201	CbGpPWpGaD
Gefitinib—ABCB1—Transmembrane transport of small molecules—SLC14A2—rectum cancer	0.000702	0.002	CbGpPWpGaD
Gefitinib—ERBB3—Signaling by SCF-KIT—HRAS—rectum cancer	0.000696	0.00199	CbGpPWpGaD
Gefitinib—EGFR—Developmental Biology—ITGA2—rectum cancer	0.000692	0.00197	CbGpPWpGaD
Gefitinib—IRAK4—Cytokine Signaling in Immune system—NRAS—rectum cancer	0.00069	0.00197	CbGpPWpGaD
Gefitinib—ERBB3—Signaling by FGFR in disease—KRAS—rectum cancer	0.000683	0.00195	CbGpPWpGaD
Gefitinib—ERBB3—Fc epsilon receptor (FCERI) signaling—KRAS—rectum cancer	0.000683	0.00195	CbGpPWpGaD
Gefitinib—ERBB3—DAP12 interactions—KRAS—rectum cancer	0.000683	0.00195	CbGpPWpGaD
Gefitinib—ERBB3—Signaling by EGFR—KRAS—rectum cancer	0.000677	0.00193	CbGpPWpGaD
Gefitinib—ERBB3—Signaling by EGFR in Cancer—KRAS—rectum cancer	0.000671	0.00191	CbGpPWpGaD
Gefitinib—EGFR—ErbB1 downstream signaling—NRAS—rectum cancer	0.000671	0.00191	CbGpPWpGaD
Gefitinib—ERBB3—Signaling by PDGF—KRAS—rectum cancer	0.000668	0.00191	CbGpPWpGaD
Gefitinib—ERBB3—Downstream signaling of activated FGFR—HRAS—rectum cancer	0.000666	0.0019	CbGpPWpGaD
Gefitinib—MAP2K5—MAPK Signaling Pathway—TP53—rectum cancer	0.000657	0.00187	CbGpPWpGaD
Gefitinib—ERBB3—Signaling by ERBB4—HRAS—rectum cancer	0.000656	0.00187	CbGpPWpGaD
Gefitinib—EPHA6—Axon guidance—KRAS—rectum cancer	0.000655	0.00187	CbGpPWpGaD
Gefitinib—MAP2K5—Insulin Signaling—HRAS—rectum cancer	0.000653	0.00186	CbGpPWpGaD
Gefitinib—MAP2K5—EGF/EGFR Signaling Pathway—HRAS—rectum cancer	0.000647	0.00184	CbGpPWpGaD
Gefitinib—ERBB3—B Cell Activation—KRAS—rectum cancer	0.000632	0.0018	CbGpPWpGaD
Gefitinib—MAP2K5—NGF signalling via TRKA from the plasma membrane—KRAS—rectum cancer	0.000628	0.00179	CbGpPWpGaD
Gefitinib—ERBB3—Downstream signal transduction—HRAS—rectum cancer	0.000626	0.00179	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways in Glioblastoma—TP53—rectum cancer	0.000625	0.00178	CbGpPWpGaD
Gefitinib—ERBB3—Signaling by FGFR—HRAS—rectum cancer	0.000623	0.00178	CbGpPWpGaD
Gefitinib—ERBB3—Signaling by ERBB2—HRAS—rectum cancer	0.00062	0.00177	CbGpPWpGaD
Gefitinib—ERBB3—DAP12 signaling—HRAS—rectum cancer	0.000617	0.00176	CbGpPWpGaD
Gefitinib—ERBB3—Downstream signaling events of B Cell Receptor (BCR)—HRAS—rectum cancer	0.000608	0.00174	CbGpPWpGaD
Gefitinib—ERBB3—NGF signalling via TRKA from the plasma membrane—KRAS—rectum cancer	0.000605	0.00173	CbGpPWpGaD
Gefitinib—CYP1A1—Aryl Hydrocarbon Receptor—HRAS—rectum cancer	0.0006	0.00171	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways in Glioblastoma—HRAS—rectum cancer	0.000598	0.00171	CbGpPWpGaD
Gefitinib—IRAK4—Cytokine Signaling in Immune system—KRAS—rectum cancer	0.000594	0.00169	CbGpPWpGaD
Gefitinib—ERBB3—Signaling by FGFR in disease—HRAS—rectum cancer	0.000581	0.00166	CbGpPWpGaD
Gefitinib—ERBB3—Fc epsilon receptor (FCERI) signaling—HRAS—rectum cancer	0.000581	0.00166	CbGpPWpGaD
Gefitinib—ERBB3—DAP12 interactions—HRAS—rectum cancer	0.000581	0.00166	CbGpPWpGaD
Gefitinib—EGFR—ErbB1 downstream signaling—KRAS—rectum cancer	0.000577	0.00165	CbGpPWpGaD
Gefitinib—ERBB3—Signaling by EGFR—HRAS—rectum cancer	0.000575	0.00164	CbGpPWpGaD
Gefitinib—ERBB3—Signaling by EGFR in Cancer—HRAS—rectum cancer	0.00057	0.00163	CbGpPWpGaD
Gefitinib—MAP2K5—Focal Adhesion—HRAS—rectum cancer	0.000569	0.00162	CbGpPWpGaD
Gefitinib—ERBB3—Signaling by PDGF—HRAS—rectum cancer	0.000568	0.00162	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling by NGF—NRAS—rectum cancer	0.000561	0.0016	CbGpPWpGaD
Gefitinib—EPHA6—Axon guidance—HRAS—rectum cancer	0.000557	0.00159	CbGpPWpGaD
Gefitinib—EPHA6—Developmental Biology—NRAS—rectum cancer	0.000543	0.00155	CbGpPWpGaD
Gefitinib—ERBB3—Signaling by NGF—NRAS—rectum cancer	0.000541	0.00154	CbGpPWpGaD
Gefitinib—ERBB3—B Cell Activation—HRAS—rectum cancer	0.000537	0.00153	CbGpPWpGaD
Gefitinib—MAP2K5—NGF signalling via TRKA from the plasma membrane—HRAS—rectum cancer	0.000533	0.00152	CbGpPWpGaD
Gefitinib—EGFR—Signaling by SCF-KIT—NRAS—rectum cancer	0.00053	0.00151	CbGpPWpGaD
Gefitinib—ERBB3—NGF signalling via TRKA from the plasma membrane—HRAS—rectum cancer	0.000514	0.00147	CbGpPWpGaD
Gefitinib—EGFR—Regulation of Actin Cytoskeleton—NRAS—rectum cancer	0.000507	0.00145	CbGpPWpGaD
Gefitinib—EGFR—Downstream signaling of activated FGFR—NRAS—rectum cancer	0.000507	0.00145	CbGpPWpGaD
Gefitinib—IRAK4—Cytokine Signaling in Immune system—HRAS—rectum cancer	0.000505	0.00144	CbGpPWpGaD
Gefitinib—EGFR—Signaling by ERBB4—NRAS—rectum cancer	0.000499	0.00142	CbGpPWpGaD
Gefitinib—EGFR—ErbB1 downstream signaling—HRAS—rectum cancer	0.000491	0.0014	CbGpPWpGaD
Gefitinib—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—rectum cancer	0.000484	0.00138	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling by NGF—KRAS—rectum cancer	0.000483	0.00138	CbGpPWpGaD
Gefitinib—EGFR—Downstream signal transduction—NRAS—rectum cancer	0.000477	0.00136	CbGpPWpGaD
Gefitinib—EGFR—Signaling by FGFR—NRAS—rectum cancer	0.000474	0.00135	CbGpPWpGaD
Gefitinib—EGFR—Signaling by ERBB2—NRAS—rectum cancer	0.000472	0.00135	CbGpPWpGaD
Gefitinib—EGFR—DAP12 signaling—NRAS—rectum cancer	0.00047	0.00134	CbGpPWpGaD
Gefitinib—EPHA6—Developmental Biology—KRAS—rectum cancer	0.000468	0.00133	CbGpPWpGaD
Gefitinib—EGFR—Spinal Cord Injury—TP53—rectum cancer	0.000467	0.00133	CbGpPWpGaD
Gefitinib—ERBB3—Signaling by NGF—KRAS—rectum cancer	0.000465	0.00133	CbGpPWpGaD
Gefitinib—EGFR—Downstream signaling events of B Cell Receptor (BCR)—NRAS—rectum cancer	0.000463	0.00132	CbGpPWpGaD
Gefitinib—EGFR—MAPK Signaling Pathway—NRAS—rectum cancer	0.000461	0.00131	CbGpPWpGaD
Gefitinib—IRAK1—Cytokine Signaling in Immune system—NRAS—rectum cancer	0.000458	0.00131	CbGpPWpGaD
Gefitinib—EGFR—Signaling by SCF-KIT—KRAS—rectum cancer	0.000456	0.0013	CbGpPWpGaD
Gefitinib—IRAK1—Signaling by NGF—NRAS—rectum cancer	0.00045	0.00128	CbGpPWpGaD
Gefitinib—EGFR—Fc epsilon receptor (FCERI) signaling—NRAS—rectum cancer	0.000442	0.00126	CbGpPWpGaD
Gefitinib—EGFR—DAP12 interactions—NRAS—rectum cancer	0.000442	0.00126	CbGpPWpGaD
Gefitinib—EGFR—Signaling by FGFR in disease—NRAS—rectum cancer	0.000442	0.00126	CbGpPWpGaD
Gefitinib—EGFR—Signaling by EGFR—NRAS—rectum cancer	0.000438	0.00125	CbGpPWpGaD
Gefitinib—EGFR—Downstream signaling of activated FGFR—KRAS—rectum cancer	0.000436	0.00125	CbGpPWpGaD
Gefitinib—EGFR—Regulation of Actin Cytoskeleton—KRAS—rectum cancer	0.000436	0.00125	CbGpPWpGaD
Gefitinib—EGFR—Signaling by EGFR in Cancer—NRAS—rectum cancer	0.000434	0.00124	CbGpPWpGaD
Gefitinib—EGFR—Signaling by PDGF—NRAS—rectum cancer	0.000432	0.00123	CbGpPWpGaD
Gefitinib—EGFR—Integrated Breast Cancer Pathway—KRAS—rectum cancer	0.000432	0.00123	CbGpPWpGaD
Gefitinib—EGFR—Signaling by ERBB4—KRAS—rectum cancer	0.00043	0.00123	CbGpPWpGaD
Gefitinib—ALB—Folate Metabolism—TP53—rectum cancer	0.000429	0.00122	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling by NGF—HRAS—rectum cancer	0.00041	0.00117	CbGpPWpGaD
Gefitinib—EGFR—Downstream signal transduction—KRAS—rectum cancer	0.00041	0.00117	CbGpPWpGaD
Gefitinib—EGFR—B Cell Activation—NRAS—rectum cancer	0.000409	0.00117	CbGpPWpGaD
Gefitinib—EGFR—Signaling by FGFR—KRAS—rectum cancer	0.000408	0.00116	CbGpPWpGaD
Gefitinib—EGFR—EGF/EGFR Signaling Pathway—KRAS—rectum cancer	0.000408	0.00116	CbGpPWpGaD
Gefitinib—EGFR—Direct p53 effectors—TP53—rectum cancer	0.000408	0.00116	CbGpPWpGaD
Gefitinib—EGFR—Signaling by ERBB2—KRAS—rectum cancer	0.000406	0.00116	CbGpPWpGaD
Gefitinib—EGFR—DAP12 signaling—KRAS—rectum cancer	0.000404	0.00115	CbGpPWpGaD
Gefitinib—EGFR—Downstream signaling events of B Cell Receptor (BCR)—KRAS—rectum cancer	0.000398	0.00114	CbGpPWpGaD
Gefitinib—EPHA6—Developmental Biology—HRAS—rectum cancer	0.000397	0.00113	CbGpPWpGaD
Gefitinib—EGFR—MAPK Signaling Pathway—KRAS—rectum cancer	0.000396	0.00113	CbGpPWpGaD
Gefitinib—ERBB3—Signaling by NGF—HRAS—rectum cancer	0.000396	0.00113	CbGpPWpGaD
Gefitinib—IRAK1—Cytokine Signaling in Immune system—KRAS—rectum cancer	0.000394	0.00112	CbGpPWpGaD
Gefitinib—EGFR—NGF signalling via TRKA from the plasma membrane—NRAS—rectum cancer	0.000391	0.00112	CbGpPWpGaD
Gefitinib—ALB—Hemostasis—ITGA2—rectum cancer	0.000391	0.00112	CbGpPWpGaD
Gefitinib—EGFR—Signaling by SCF-KIT—HRAS—rectum cancer	0.000388	0.00111	CbGpPWpGaD
Gefitinib—IRAK1—Signaling by NGF—KRAS—rectum cancer	0.000387	0.00111	CbGpPWpGaD
Gefitinib—IRAK4—Innate Immune System—NRAS—rectum cancer	0.000387	0.0011	CbGpPWpGaD
Gefitinib—EGFR—Integrated Breast Cancer Pathway—TP53—rectum cancer	0.000384	0.00109	CbGpPWpGaD
Gefitinib—EGFR—Signaling by FGFR in disease—KRAS—rectum cancer	0.00038	0.00108	CbGpPWpGaD
Gefitinib—EGFR—DAP12 interactions—KRAS—rectum cancer	0.00038	0.00108	CbGpPWpGaD
Gefitinib—EGFR—Fc epsilon receptor (FCERI) signaling—KRAS—rectum cancer	0.00038	0.00108	CbGpPWpGaD
Gefitinib—CHEK2—Cell Cycle—TP53—rectum cancer	0.000379	0.00108	CbGpPWpGaD
Gefitinib—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—rectum cancer	0.000378	0.00108	CbGpPWpGaD
Gefitinib—EGFR—Signaling by EGFR—KRAS—rectum cancer	0.000377	0.00108	CbGpPWpGaD
Gefitinib—EGFR—Signaling by EGFR in Cancer—KRAS—rectum cancer	0.000374	0.00107	CbGpPWpGaD
Gefitinib—EGFR—Signaling by PDGF—KRAS—rectum cancer	0.000372	0.00106	CbGpPWpGaD
Gefitinib—EGFR—Downstream signaling of activated FGFR—HRAS—rectum cancer	0.000371	0.00106	CbGpPWpGaD
Gefitinib—EGFR—Signaling by ERBB4—HRAS—rectum cancer	0.000365	0.00104	CbGpPWpGaD
Gefitinib—EGFR—Integrated Pancreatic Cancer Pathway—KRAS—rectum cancer	0.000358	0.00102	CbGpPWpGaD
Gefitinib—EGFR—MAPK Signaling Pathway—TP53—rectum cancer	0.000352	0.00101	CbGpPWpGaD
Gefitinib—EGFR—B Cell Activation—KRAS—rectum cancer	0.000352	0.001	CbGpPWpGaD
Gefitinib—EGFR—Downstream signal transduction—HRAS—rectum cancer	0.000349	0.000995	CbGpPWpGaD
Gefitinib—EGFR—Signaling by FGFR—HRAS—rectum cancer	0.000347	0.00099	CbGpPWpGaD
Gefitinib—EGFR—EGF/EGFR Signaling Pathway—HRAS—rectum cancer	0.000347	0.00099	CbGpPWpGaD
Gefitinib—EGFR—Signaling by ERBB2—HRAS—rectum cancer	0.000345	0.000985	CbGpPWpGaD
Gefitinib—EGFR—DAP12 signaling—HRAS—rectum cancer	0.000344	0.00098	CbGpPWpGaD
Gefitinib—EGFR—Downstream signaling events of B Cell Receptor (BCR)—HRAS—rectum cancer	0.000339	0.000966	CbGpPWpGaD
Gefitinib—EGFR—NGF signalling via TRKA from the plasma membrane—KRAS—rectum cancer	0.000337	0.000961	CbGpPWpGaD
Gefitinib—IRAK1—Cytokine Signaling in Immune system—HRAS—rectum cancer	0.000335	0.000955	CbGpPWpGaD
Gefitinib—IRAK4—Innate Immune System—KRAS—rectum cancer	0.000333	0.00095	CbGpPWpGaD
Gefitinib—IRAK1—Signaling by NGF—HRAS—rectum cancer	0.000329	0.000939	CbGpPWpGaD
Gefitinib—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—rectum cancer	0.000325	0.000929	CbGpPWpGaD
Gefitinib—CSNK1E—Cell Cycle—TP53—rectum cancer	0.000325	0.000926	CbGpPWpGaD
Gefitinib—EGFR—Fc epsilon receptor (FCERI) signaling—HRAS—rectum cancer	0.000323	0.000922	CbGpPWpGaD
Gefitinib—EGFR—DAP12 interactions—HRAS—rectum cancer	0.000323	0.000922	CbGpPWpGaD
Gefitinib—EGFR—Signaling by FGFR in disease—HRAS—rectum cancer	0.000323	0.000922	CbGpPWpGaD
Gefitinib—EGFR—Signaling by EGFR—HRAS—rectum cancer	0.00032	0.000914	CbGpPWpGaD
Gefitinib—EGFR—Integrated Pancreatic Cancer Pathway—TP53—rectum cancer	0.000318	0.000907	CbGpPWpGaD
Gefitinib—EGFR—Signaling by EGFR in Cancer—HRAS—rectum cancer	0.000317	0.000906	CbGpPWpGaD
Gefitinib—EGFR—Signaling by PDGF—HRAS—rectum cancer	0.000316	0.000902	CbGpPWpGaD
Gefitinib—ERBB3—Innate Immune System—NRAS—rectum cancer	0.000308	0.00088	CbGpPWpGaD
Gefitinib—EGFR—Focal Adhesion—HRAS—rectum cancer	0.000305	0.000871	CbGpPWpGaD
Gefitinib—EGFR—Signaling by NGF—NRAS—rectum cancer	0.000301	0.000859	CbGpPWpGaD
Gefitinib—EGFR—B Cell Activation—HRAS—rectum cancer	0.000299	0.000853	CbGpPWpGaD
Gefitinib—ERBB3—Adaptive Immune System—NRAS—rectum cancer	0.000296	0.000845	CbGpPWpGaD
Gefitinib—EGFR—NGF signalling via TRKA from the plasma membrane—HRAS—rectum cancer	0.000286	0.000817	CbGpPWpGaD
Gefitinib—IRAK4—Innate Immune System—HRAS—rectum cancer	0.000283	0.000807	CbGpPWpGaD
Gefitinib—MKNK1—Disease—NRAS—rectum cancer	0.00028	0.000798	CbGpPWpGaD
Gefitinib—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—rectum cancer	0.000277	0.000789	CbGpPWpGaD
Gefitinib—EGFR—Axon guidance—NRAS—rectum cancer	0.000272	0.000777	CbGpPWpGaD
Gefitinib—ERBB3—Innate Immune System—KRAS—rectum cancer	0.000265	0.000757	CbGpPWpGaD
Gefitinib—EGFR—Signaling by NGF—KRAS—rectum cancer	0.000259	0.000739	CbGpPWpGaD
Gefitinib—IRAK1—Innate Immune System—NRAS—rectum cancer	0.000257	0.000732	CbGpPWpGaD
Gefitinib—ERBB3—Adaptive Immune System—KRAS—rectum cancer	0.000255	0.000727	CbGpPWpGaD
Gefitinib—MKNK1—Disease—KRAS—rectum cancer	0.000241	0.000687	CbGpPWpGaD
Gefitinib—EGFR—Axon guidance—KRAS—rectum cancer	0.000234	0.000669	CbGpPWpGaD
Gefitinib—ERBB3—Innate Immune System—HRAS—rectum cancer	0.000226	0.000644	CbGpPWpGaD
Gefitinib—IRAK4—Immune System—NRAS—rectum cancer	0.000225	0.000643	CbGpPWpGaD
Gefitinib—IRAK1—Innate Immune System—KRAS—rectum cancer	0.000221	0.00063	CbGpPWpGaD
Gefitinib—EGFR—Signaling by NGF—HRAS—rectum cancer	0.00022	0.000628	CbGpPWpGaD
Gefitinib—CSNK1E—Disease—NRAS—rectum cancer	0.000218	0.000621	CbGpPWpGaD
Gefitinib—ERBB3—Adaptive Immune System—HRAS—rectum cancer	0.000217	0.000618	CbGpPWpGaD
Gefitinib—MKNK1—Disease—HRAS—rectum cancer	0.000205	0.000584	CbGpPWpGaD
Gefitinib—EGFR—Axon guidance—HRAS—rectum cancer	0.000199	0.000569	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—NRAS—rectum cancer	0.000196	0.000559	CbGpPWpGaD
Gefitinib—EGFR—Developmental Biology—NRAS—rectum cancer	0.000194	0.000555	CbGpPWpGaD
Gefitinib—IRAK4—Immune System—KRAS—rectum cancer	0.000194	0.000553	CbGpPWpGaD
Gefitinib—IRAK1—Innate Immune System—HRAS—rectum cancer	0.000188	0.000536	CbGpPWpGaD
Gefitinib—CSNK1E—Disease—KRAS—rectum cancer	0.000187	0.000534	CbGpPWpGaD
Gefitinib—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—rectum cancer	0.000181	0.000515	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—NRAS—rectum cancer	0.00018	0.000512	CbGpPWpGaD
Gefitinib—EGFR—Innate Immune System—NRAS—rectum cancer	0.000172	0.00049	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—KRAS—rectum cancer	0.000169	0.000481	CbGpPWpGaD
Gefitinib—EGFR—Developmental Biology—KRAS—rectum cancer	0.000167	0.000477	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—TYMS—rectum cancer	0.000166	0.000475	CbGpPWpGaD
Gefitinib—ERBB3—Disease—NRAS—rectum cancer	0.000166	0.000473	CbGpPWpGaD
Gefitinib—EGFR—Adaptive Immune System—NRAS—rectum cancer	0.000165	0.00047	CbGpPWpGaD
Gefitinib—IRAK4—Immune System—HRAS—rectum cancer	0.000165	0.00047	CbGpPWpGaD
Gefitinib—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—rectum cancer	0.000161	0.000458	CbGpPWpGaD
Gefitinib—CSNK1E—Disease—HRAS—rectum cancer	0.000159	0.000454	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—KRAS—rectum cancer	0.000155	0.000441	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—NRAS—rectum cancer	0.000152	0.000435	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—TP53—rectum cancer	0.00015	0.000428	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—NRAS—rectum cancer	0.00015	0.000427	CbGpPWpGaD
Gefitinib—EGFR—Innate Immune System—KRAS—rectum cancer	0.000148	0.000422	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—HRAS—rectum cancer	0.000143	0.000409	CbGpPWpGaD
Gefitinib—ERBB3—Disease—KRAS—rectum cancer	0.000143	0.000407	CbGpPWpGaD
Gefitinib—EGFR—Developmental Biology—HRAS—rectum cancer	0.000142	0.000406	CbGpPWpGaD
Gefitinib—EGFR—Adaptive Immune System—KRAS—rectum cancer	0.000142	0.000405	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—HRAS—rectum cancer	0.000131	0.000375	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—KRAS—rectum cancer	0.000131	0.000374	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—KRAS—rectum cancer	0.000129	0.000367	CbGpPWpGaD
Gefitinib—EGFR—Innate Immune System—HRAS—rectum cancer	0.000126	0.000358	CbGpPWpGaD
Gefitinib—ERBB3—Disease—HRAS—rectum cancer	0.000121	0.000346	CbGpPWpGaD
Gefitinib—EGFR—Adaptive Immune System—HRAS—rectum cancer	0.000121	0.000344	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—NRAS—rectum cancer	0.00012	0.000344	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—TYMS—rectum cancer	0.000119	0.00034	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—TP53—rectum cancer	0.000117	0.000333	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—NRAS—rectum cancer	0.000116	0.000331	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—TYMS—rectum cancer	0.000113	0.000321	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—HRAS—rectum cancer	0.000111	0.000318	CbGpPWpGaD
Gefitinib—ALB—Hemostasis—NRAS—rectum cancer	0.00011	0.000313	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—NRAS—rectum cancer	0.000109	0.000312	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—HRAS—rectum cancer	0.000109	0.000312	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—KRAS—rectum cancer	0.000104	0.000296	CbGpPWpGaD
Gefitinib—ALB—Metabolism—TYMS—rectum cancer	0.000103	0.000293	CbGpPWpGaD
Gefitinib—EGFR—Immune System—NRAS—rectum cancer	0.0001	0.000285	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—KRAS—rectum cancer	9.99e-05	0.000285	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—NRAS—rectum cancer	9.67e-05	0.000276	CbGpPWpGaD
Gefitinib—ALB—Hemostasis—KRAS—rectum cancer	9.45e-05	0.00027	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—KRAS—rectum cancer	9.42e-05	0.000269	CbGpPWpGaD
Gefitinib—EGFR—Disease—NRAS—rectum cancer	9.23e-05	0.000263	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—TYMS—rectum cancer	9.22e-05	0.000263	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—TP53—rectum cancer	9.22e-05	0.000263	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—TYMS—rectum cancer	9e-05	0.000257	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—TP53—rectum cancer	8.88e-05	0.000253	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—HRAS—rectum cancer	8.81e-05	0.000251	CbGpPWpGaD
Gefitinib—EGFR—Immune System—KRAS—rectum cancer	8.61e-05	0.000246	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—HRAS—rectum cancer	8.49e-05	0.000242	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—TYMS—rectum cancer	8.48e-05	0.000242	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—TYMS—rectum cancer	8.41e-05	0.00024	CbGpPWpGaD
Gefitinib—ALB—Hemostasis—TP53—rectum cancer	8.4e-05	0.00024	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—KRAS—rectum cancer	8.32e-05	0.000237	CbGpPWpGaD
Gefitinib—ALB—Hemostasis—HRAS—rectum cancer	8.04e-05	0.000229	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—HRAS—rectum cancer	8.01e-05	0.000228	CbGpPWpGaD
Gefitinib—EGFR—Disease—KRAS—rectum cancer	7.95e-05	0.000227	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—TP53—rectum cancer	7.4e-05	0.000211	CbGpPWpGaD
Gefitinib—EGFR—Immune System—HRAS—rectum cancer	7.31e-05	0.000209	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—HRAS—rectum cancer	7.07e-05	0.000202	CbGpPWpGaD
Gefitinib—EGFR—Disease—HRAS—rectum cancer	6.75e-05	0.000193	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—NRAS—rectum cancer	6.46e-05	0.000184	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—KRAS—rectum cancer	5.56e-05	0.000159	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—TYMS—rectum cancer	5.54e-05	0.000158	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—TP53—rectum cancer	4.94e-05	0.000141	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—HRAS—rectum cancer	4.73e-05	0.000135	CbGpPWpGaD
